BioNTech (Germany) Analysis

BioNTech Stock Analysis Notes

About 64.0% of the company shares are owned by insiders or employees . The book value of BioNTech was presently reported as 76.45. The company has Price/Earnings To Growth (PEG) ratio of 0.04. BioNTech SE recorded earning per share (EPS) of 38.32. The entity last dividend was issued on the 2nd of June 2022. BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany. BIONTECH operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2500 people. For more info on BioNTech SE please contact the company at 49 6131 9084 0 or go to https://www.biontech.de.

BioNTech SE Investment Alerts

BioNTech Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 30.49 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioNTech's market, we take the total number of its shares issued and multiply it by BioNTech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

BioNTech Profitablity

The company has Profit Margin (PM) of 0.56 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.68 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.68.

Technical Drivers

As of the 21st of March, BioNTech shows the Mean Deviation of 2.09, risk adjusted performance of (0.08), and Standard Deviation of 2.8. BioNTech SE technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm BioNTech SE standard deviation, information ratio, maximum drawdown, as well as the relationship between the variance and treynor ratio to decide if BioNTech SE is priced correctly, providing market reflects its regular price of 92.65 per share.

BioNTech SE Price Movement Analysis

BioNTech Outstanding Bonds

BioNTech Predictive Daily Indicators

BioNTech Forecast Models

BioNTech's time-series forecasting models are one of many BioNTech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BioNTech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how BioNTech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BioNTech shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as BioNTech. By using and applying BioNTech Stock analysis, traders can create a robust methodology for identifying BioNTech entry and exit points for their positions.

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.